Navigation Links
Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries)
Date:12/8/2009

6.12.2.1 Market Analysis and Forecast ....222

6.12.2.2 Competitive Analysis ...... 224

PTCA BALLOON CATHETERS ......... 225

7.1 INTRODUCTION ... 225

7.1.1 Conventional and Cutting Balloons ... 225

7.1.2 Units per Procedure 226

7.1.3 Drug-Eluting Balloons ............. 227

7.2 MARKET ANALYSIS AND FORECAST ....... 228

7.3 MARKET DRIVERS AND LIMITERS . 237

7.3.1 Market Drivers 237

7.3.2 Market Limiters ......... 238

7.4 COMPETITIVE ANALYSIS 239

INTERVENTIONAL CATHETERS .... 242

8.1 INTRODUCTION ... 242

8.1.1 Units per Procedure 243

8.2 MARKET ANALYSIS AND FORECAST ....... 244

8.3 MARKET DRIVERS AND LIMITERS . 256

8.3.1 Market Drivers 256

8.3.2 Market Limiters ......... 257

8.4 COMPETITIVE ANALYSIS 258

INTERVENTIONAL GUIDEWIRES 261

9.1 INTRODUCTION ... 261

9.1.1 Conventional and Specialty Guidewires ......... 261

9.1.2 Material and Fabrication ...... 261

9.2 OVERVIEW OF THE MARKET .......... 262

9.2.1 Market Analysis and Forecast . 262

9.2.2 Specialized Guidewires Market ......... 270

9.3 MARKET DRIVERS AND LIMITERS . 271

9.3.1 Market Drivers 271

9.3.2 Market Limiters ......... 271

9.4 COMPETITIVE ANALYSIS 273

INTRODUCER SHEATHS .... 275

10.1 INTRODUCTION ... 275

10.1.1 The Femoral Approach .......... 276

10.1.2 Transradial/Brachial Approach ....... 276

10.2 MARKET ANALYSIS AND FORECAST ... 277

10.2.1 Market Analysis and Forecast ......... 277

10.2.2 Market by Country 277

10.3 MARKET DRIVERS AND LIMITERS ......... 286

10.3.1 Market Drivers ...... 286

10.3.2 Market Limiters ....... 286

10.4 COMPETI
'/>"/>

SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related medicine news :

1. Reportlinker Adds Biologic Imaging Reagents: Technologies and Global Markets Report
2. Reportlinker Adds Dermatological Therapeutics: Global Markets Report
3. Reportlinker Adds Markets for Advanced Wound Care Technologies Report
4. Reportlinker Adds Antiseptics and Disinfectants Report
5. Reportlinker Adds Commercial Amino Acids Report
6. Reportlinker Adds Membrane & Separation Technology News Review, 2008 Report
7. Reportlinker Adds the Dental Market: Techniques, Equipment and Materials Report
8. Reportlinker Adds Pediatric Health Care Products and Services Report
9. Reportlinker Adds Botanical and Plant-Derived Drugs: Global Markets Report
10. Reportlinker Adds 2008/2009 Healthcare Research Review Report
11. Reportlinker Adds Therapeutics and Diagnostics for Womens Disorders Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... NY (PRWEB) November 26, 2014 Call ... research requirements or email the details on sales(at)researchmoz(dot)us ... diabetes and drug discovery market 2014" with deep study ... is the result of high blood sugar. The global ... directly linked to the growing number of diabetics in ...
(Date:11/26/2014)... Aurora, CO (PRWEB) November 26, 2014 For ... fast, the new LES MILLS BODYPUMP™ classes at ... be just the workout they've been looking for. The 45- ... with CU Anschutz Health and Wellness Center fitness club memberships. ... muscles. The workouts are fast-paced and are aimed at fast ...
(Date:11/26/2014)... Sonoran Vein and Endovascular nurse, ... Distinguished Preceptorship Award from The American Association ... the advancement of nurse practitioners. The Distinguished Preceptorship ... had made a significant contribution toward increasing the ... of Nurse Practitioners (AANP) is the largest full-service ...
(Date:11/26/2014)... 25, 2014 (HealthDay News) -- Vultures have developed highly ... ingest when eating dead animals, researchers report. The ... on the faces and in the guts of 50 ... On average, the faces of the vultures had more ... in their guts, the study found. The findings ...
(Date:11/26/2014)... -- Exposure to peanut protein in household dust may ... the skin condition eczema, a new study reveals. ... States are allergic to peanuts. And severe eczema in ... allergy, the researchers noted. The new study included ... researchers examined the amount of peanut protein the children ...
Breaking Medicine News(10 mins):Health News:Latest Report on Diabetes Market 2014 - Global Market Size, Share, Trends and Forecast by Researchmoz.us 2Health News:Latest Report on Diabetes Market 2014 - Global Market Size, Share, Trends and Forecast by Researchmoz.us 3Health News:LES MILLS BODYPUMP™ classes come to the University of Colorado Anschutz Health and Wellness Center 2Health News:Sonoran Nurse Receives Distinguished Preceptorship Award from The American Association of Nurse Practitioners 2Health News:Infants With Eczema May Be More Prone to Peanut Allergy: Study 2
... , Gross margin increases by 540 percent , ... Sinobiopharma, Inc. (OTC Bulletin Board: SNBP)("Sinobiopharma", or the "Company") is pleased to ... 30, 2008 for Sinobiopharma,s operating subsidiary, Dong Ying (Jiangsu) Pharmaceutical Co., Ltd. ... include: , , , ...
... Inc. (NYSE:, WLP ) today announced the appointment ... Application Development. In this role, he will be responsible ... , "A.J. adds ... years of technical and leadership experience in health care, ...
... cites misperceptions regarding need for vaccination and a lack of time ... ... Bethesda, MD (PRWEB) December 10, 2008 -- A new ... (29.6 percent) have been vaccinated against the flu this season. The ...
... Calif., Dec. 10 As part of the ... examination of the commonly,prescribed asthma drugs Advair, Symbicort, ... Pulmonary Medicine, St. Francis Hospital, and Dr.,James Wolfe, ... are available to discuss exhaled nitric oxide monitoring ...
... Computational Neuroscience at UC San Diego will create a ... subjects engaged in normal activity in ordinary room environments. ... year, $3.4 million research grant from the U.S. Navy ... brain and body imaging modality MoBI ("Mobile Brain/Body Imaging") ...
... In an unprecedented effort to,address the health ... has,developed numerous tools, services, and programs now available ... BCBSF,s goal is to,provide the resources necessary to ... and the value of insurance in a culture-specific ...
Cached Medicine News:Health News:Sinobiopharma Reports Highlights of Third Quarter Results for Its Operating Subsidiary, Dong Ying China 2Health News:WellPoint Announces Appointment of Andrew J. Lang as Senior Vice President of Application Development 2Health News:Mid-Season Flu Immunization Rates are Too Low 2Health News:Mid-Season Flu Immunization Rates are Too Low 3Health News:Mid-Season Flu Immunization Rates are Too Low 4Health News:Mid-Season Flu Immunization Rates are Too Low 5Health News:Experts Highlight New Tool as a Timely Addition to Asthma Treatment 2Health News:Blue Cross and Blue Shield of Florida Champions Health Care Education and Access for Florida's Hispanic Community 2
(Date:11/26/2014)... Nov. 25, 2014  Medtronic,s roughly $43 ... been widely discussed in the media for its ... a stronger leading player in one of the ... The healthcare market research firm said  the two ... a diverse set of solutions spanning inpatient to ...
(Date:11/26/2014)... YORK, Pa. , Nov. 25, 2014  Unilife ... supplier of injectable drug delivery systems, today announced that ... scheduled to present at the Piper Jaffray 26th Annual ... 8:30 a.m. EST on Tuesday, December 2, 2014. ... the Internet as a "live" listen only Webcast. To ...
(Date:11/26/2014)... and LONDON , Nov. 25, 2014 ... (NYSE: AZN ) today announced that AMAGINE-2 TM ... of brodalumab in more than 1,800 patients with moderate-to-severe plaque ... ® (ustekinumab) and placebo at week 12. Brodalumab 210 ... group were each shown to be superior to Stelara on ...
Breaking Medicine Technology:Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 2Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 3Unilife to Present at the Piper Jaffray 26th Annual Healthcare Conference on December 2nd 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 3Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 4Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 5Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 6Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 7Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 8Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 9Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 10
... UPI ) announced today that it will release financial ... at the market close on Monday, November 2, 2009. ... results on Monday, November 2, 2009 at 3:30 p.m. Central ... Medi Jiwani, Vice President, Chief Financial Officer and Treasurer, will ...
... 21 Shire plc,(LSE: SHP, NASDAQ: SHPGY ), ... Biologics License Application (BLA) with the U.S.,Food and Drug ... for Fabry disease, by the end of the year. ... filed at the,request of FDA, has been approved, and ...
Cached Medicine Technology:Uroplasty to Issue Second Fiscal Quarter Results on November 2, 2009 2Shire Targets Fourth Quarter Filing of BLA for REPLAGAL(R) for Fabry Disease With U.S. FDA 2Shire Targets Fourth Quarter Filing of BLA for REPLAGAL(R) for Fabry Disease With U.S. FDA 3Shire Targets Fourth Quarter Filing of BLA for REPLAGAL(R) for Fabry Disease With U.S. FDA 4
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: